Impact of surgical resection of liver metastases on outcome of patients with KRAS-wildtype exon 2 (KRAS-wt) metastatic colorectal carcinoma (mCRC) treated with a cetuximab-based first-line therapy - Interim analysis of the German non-interventional study ERBITAG
Neumann, U., Goehler, T., Hering-Schubert, C., Janssen, J., Sahm, S., Schwittay, M., Zahn, M.O., Stenzel, K.G., Overkamp, F.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Nab-paclitaxel/gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values - Data from the German QoliXane pancreatic cancer registry
Hausen, Gzur, Waidmann, O., Woerns, M.A., Hoeffkes, H.G., Doerfel, S., Zahn, M.O., Aldaoud, A., Stauch, M., Springfeld, C., Haertel, N., Reichart, A., Goetze, T.O., Schwarz, S., Pauligk, C., Roemmler-Zehrer, J., Hofheinz, R.D., Al-Batran, S.-E.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Thrombin as a survival factor for cancer cells: thrombin activation in malignant effusions in vivo and inhibition of idarubicin-induced cell death in vitro
Schiller, H, Bartscht, T, Arlt, A, Zahn, M O, Seifert, A, Bruhn, T, Bruhn, H D, Gieseler, F
Published in International journal of clinical pharmacology and therapeutics (01.08.2002)
Published in International journal of clinical pharmacology and therapeutics (01.08.2002)
Get more information
Journal Article